Insider Selling: Annexon, Inc. (NASDAQ:ANNX) Insider Sells 5,521 Shares of Stock

Annexon, Inc. (NASDAQ:ANNX - Get Free Report) insider Jamie Dananberg sold 5,521 shares of the business's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $2.96, for a total value of $16,342.16. Following the sale, the insider now owns 33,479 shares in the company, valued at approximately $99,097.84. The trade was a 14.16 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Annexon Price Performance

ANNX stock traded down $0.02 during midday trading on Thursday, hitting $2.83. 796,392 shares of the stock traded hands, compared to its average volume of 1,392,680. Annexon, Inc. has a 1-year low of $2.63 and a 1-year high of $8.40. The stock's fifty day simple moving average is $4.33 and its 200-day simple moving average is $5.59. The firm has a market cap of $301.65 million, a P/E ratio of -2.70 and a beta of 1.07.

Institutional Investors Weigh In On Annexon

Institutional investors have recently modified their holdings of the business. SG Americas Securities LLC raised its holdings in Annexon by 117.8% in the 3rd quarter. SG Americas Securities LLC now owns 32,763 shares of the company's stock worth $194,000 after purchasing an additional 17,723 shares during the period. Creative Planning grew its holdings in Annexon by 29.5% in the third quarter. Creative Planning now owns 34,779 shares of the company's stock valued at $206,000 after purchasing an additional 7,914 shares during the period. Hennion & Walsh Asset Management Inc. increased its position in shares of Annexon by 34.7% in the third quarter. Hennion & Walsh Asset Management Inc. now owns 259,404 shares of the company's stock valued at $1,536,000 after buying an additional 66,792 shares in the last quarter. GSA Capital Partners LLP raised its stake in shares of Annexon by 10.7% during the 3rd quarter. GSA Capital Partners LLP now owns 34,581 shares of the company's stock worth $205,000 after buying an additional 3,355 shares during the period. Finally, Mutual of America Capital Management LLC raised its stake in shares of Annexon by 3.1% during the 3rd quarter. Mutual of America Capital Management LLC now owns 659,254 shares of the company's stock worth $3,903,000 after buying an additional 19,681 shares during the period.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. HC Wainwright reiterated a "buy" rating and issued a $30.00 price target on shares of Annexon in a report on Tuesday, December 17th. Needham & Company LLC restated a "buy" rating and set a $16.00 target price on shares of Annexon in a research report on Friday, November 15th. Finally, Cantor Fitzgerald reiterated an "overweight" rating on shares of Annexon in a research note on Friday, November 15th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of "Buy" and a consensus target price of $15.80.

Annexon Company Profile

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.